U-BIOS

Q:BIOS - BIOPLUS ACQUISITION CORP - http://www.bioscript.com

20:21:22 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOS - Q	DEFUNCT					10.795							11.68 10.05	Oct 06	Oct 04	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - All 0 today

More trades...

Time ET	Ex	Price	Change	Volume

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-10-04 07:30	U:BIOS	News Release200	Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
2023-10-04 07:30	U:BIOS	News Release200	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
2023-08-16 08:30	U:BIOS	News Release200	Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
2023-07-17 08:00	U:BIOS	News Release200	Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical ¢ € ™s Board of Directors
2023-06-13 08:30	U:BIOS	News Release200	Avertix ¢ € ™s Guardian ¢ „ ¢ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
2023-05-03 08:30	U:BIOS	News Release200	Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

Date ET

Symbol

Type

Headline

2023-10-04 07:30

U:BIOS

News Release

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination

2023-10-04 07:30

U:BIOS

News Release

BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate